Showing 1-10 of about 35 articles.
AXIM BIOTECHNOLOGIES, INC
NEW YORK , Sept. 10, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech,” “AXIM” or “the Company”) (OTCQB: AXIM), a world leader in cannabinoid research and development, announced...
Fior Markets
New Jersey, NJ, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Rising incidence of liver cancer and growing research activities for developing novel treatments. The global liver cancer treatment market is...
Reports and Data
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Colorectal Cancer market offers an extensive analysis of the trends to estimate its growth in the near future. It provides historical...
Fortune Business Insights
Pune, July 08, 2019 (GLOBE NEWSWIRE) -- The increasing number of breast cancer cases all over the world is anticipated to boost the global Breast Cancer Therapeutics Market at promising rates, finds...
Fortune Business Insights
Pune, June 27, 2019 (GLOBE NEWSWIRE) -- Targeted segment is forecast to emerge dominant among various therapies in the Lung Cancer Therapeutics Market, finds Fortune Business Insights in a new...
Reports And Data
Increase in the understanding of diseases and research into the development of new drugs for non-small cell lung cancer is fueling the market growth. Market Size – USD 6.45 Billion in 2018, Market...
Trivedi Global, Inc.
Las Vegas, Nevada, US, June 04, 2019 (GLOBE NEWSWIRE) -- Gopal Nayak, today released research results on the beneficial impact of biofield energy treatment on improving physicochemical properties of...
Reports And Data
Increasing demand for home care nutritional products and increasing demand to meet cancer patient’s nutritional requirements are the major factors driving oncology nutritional market growth. Market...
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC:AXIM), a world leader in cannabinoid research and development, today...
Oncotelic Inc
Phase 2 Clinical Data Presented at 11th AACR-JCA Joint Conference on Breakthroughs in Cancer Research:Biology to Precision MedicineOT-101 exhibited promising single agent clinical activity as second...
Showing 1-10 of about 35 articles.
